Related Experiment Video
Updated: Aug 23, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Stroke and the total artificial heart: neurologic considerations
1Department of Medicine (Neurology), University of Texas Health Science Center, San Antonio, Texas 78284, USA.
Insights
Total artificial heart (TAH) patients frequently experience strokes from blood clots. Managing anticoagulation after a stroke requires careful consideration of bleeding risks versus recurrent embolism, especially with potential infective endocarditis.
Area of Science:
- Cardiovascular Surgery
- Neurology
- Critical Care Medicine
Background:
- Total artificial heart (TAH) implantation is associated with frequent and severe neurologic complications, primarily ischemic stroke.
- Strokes in TAH patients often result from emboli originating from prosthetic surfaces, typically affecting the middle cerebral artery.
- Cardioembolic strokes present abruptly and have a propensity for hemorrhagic transformation.
Purpose of the Study:
- To discuss the complexities of managing acute stroke in patients with total artificial hearts.
- To provide recommendations for anticoagulation strategies in TAH patients experiencing stroke.
- To address the risks of infective endocarditis and its impact on stroke management in TAH recipients.
Main Methods:
- Review of existing literature on neurologic complications following TAH implantation.
- Analysis of stroke mechanisms, including cardioembolism and prosthetic surface thrombogenesis.
- Evaluation of anticoagulation risks and benefits in the context of stroke and potential infective endocarditis.
Main Results:
- Anticoagulation management is critical, balancing the risk of hemorrhagic transformation against recurrent embolism.
- Temporary cessation of anticoagulation (24-48 hours) may be advisable for large cardioembolic infarcts.
- Infective endocarditis presents a complex scenario, potentially necessitating continued anticoagulation despite stroke.
Conclusions:
- Stroke management in TAH patients requires individualized anticoagulation strategies.
- Careful consideration of bleeding risk, stroke etiology, and prosthetic material is essential.
- Recommendations are provided for optimizing acute stroke care in the TAH population.
Abstract:
Neurologic complications, particularly brain infarction (ischemic stroke), are frequent and serious sequelae of total artificial heart (TAH) implantation. Most strokes that occur in TAH patients are due to embolism of thrombotic fragments originating on prosthetic surfaces. The emboli tend to lodge in the middle cerebral artery or its cortical branches and cause cortical syndromes. Cardioembolic strokes are characteristically heralded by the abrupt onset of a maximal neurologic deficit in an awake, often active patient. Cardioembolic strokes have a tendency to undergo hemorrhagic transformation. Anticoagulation is a major issue in stroke management: In anticoagulated patients, hemorrhagic transformation often results in major neurologic worsening; therefore, this risk must be weighed against the danger of recurrent embolism in the absence of anticoagulation. We recommend avoiding anticoagulation during the initial 24 to 48 hours after a stroke, especially in patients with large cardioembolic infarcts. Because of the many invasive procedures producing bacteremia in TAH patients, combined with the large area of prosthetic surfaces, infective endocarditis is a potential concern. Weighing the risks and benefits of anticoagulation in patients with infective endocarditis is likely to produce a controversial choice. Anticoagulation should probably be continued in such patients if they have total artificial hearts. The following article discusses the foregoing issues and presents recommendations for managing acute stroke in TAH patients.
Related Concept Videos
Stroke: Introduction and Types
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
